Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PaxVax gets rights to Crucell Switzerland's oral typhoid vaccine

Executive Summary

PaxVax Inc. (infectious disease vaccines) acquired rights to Crucell Switzerland AG’s (formerly Berna Biotech; acquired by Johnson & Johnson in 2010) oral typhoid vaccine Vivotif and its Swiss manufacturing facility.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
Deal Status
  • Final
Deal Type
  • Alliance
    • Intra-Biotech Deal
    • Reverse Licensing
    • Marketing-Licensing